DOUTOR NICHIRES Holdings Co., Ltd. (3087.T) Comparison with companies in other sectors?

DOUTOR NICHIRES Holdings Co., Ltd. has a share price of 42.49M. You can analyze DOUTOR NICHIRES Holdings Co., Ltd. (3087.T) competitors across different market sectors through stock heatmaps.

What are 3087.T's NET and operating margins?

DOUTOR NICHIRES Holdings Co., Ltd. (3087.T) operating margin is around 0.06, and net profit margin is approximately 0.05 as of the latest reports.

In what way does 3087.T's earnings per share (EPS) trend reflect its financial momentum?

DOUTOR NICHIRES Holdings Co., Ltd. (3087.T) EPS is 150.39 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for DOUTOR NICHIRES Holdings Co., Ltd. is 17.26, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for DOUTOR NICHIRES Holdings Co., Ltd.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for DOUTOR NICHIRES Holdings Co., Ltd. like P/E which is 16.55, P/B which is 1.10, and PEG which is 1.82. Compare them with sector averages to evaluate if the stock is priced fairly.

DOUTOR NICHIRES Holdings Co., Ltd.

3087.T•JPX

Consumer Cyclical

Restaurants

¥2595.00

¥11.00(0.43%)

DOUTOR NICHIRES Holdings Co., Ltd. (3087.T) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$150.39

P/E Ratio

17.26

ROE

0.07%

Net Margin

0.05%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$110.27B

Shares OutstandingTotal number of shares issued

$42.49M

Book Value/ShareNet worth per share

$2377.57

Revenue/ShareAnnual revenue per share

$3390.78

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$150.39

Net MarginNet income as percentage of revenue

4.62%

Operating MarginOperating income as percentage of revenue

6.45%

ROEReturn on shareholders' equity

6.71%

ROAReturn on total assets

5.13%

ROCEReturn on capital employed

8.48%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

$888.35

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$48.00

Dividend YieldAnnual dividend as percentage of stock price

1.85%

Financial Ratios Analysis data is not available for 3087.TFinancial Ratios Analysis details for 3087.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 3087.TSector Benchmarking details for 3087.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for DOUTOR NICHIRES Holdings Co., Ltd. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of DOUTOR NICHIRES Holdings Co., Ltd.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account DOUTOR NICHIRES Holdings Co., Ltd.'s unique business strengths and challenges.

Key Financial Metrics for DOUTOR NICHIRES Holdings Co., Ltd.

For DOUTOR NICHIRES Holdings Co., Ltd., essential financial indicators include EPS 150.39, PE 17.26, and ROE 0.07. These key ratios reveal insights into DOUTOR NICHIRES Holdings Co., Ltd.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare DOUTOR NICHIRES Holdings Co., Ltd. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of DOUTOR NICHIRES Holdings Co., Ltd.

Metrics like Net Margin 4.62% and ROA 5.13% shed light on how well DOUTOR NICHIRES Holdings Co., Ltd. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether DOUTOR NICHIRES Holdings Co., Ltd. can sustain its operations and continue growing in the future.

Valuation and Market Position of DOUTOR NICHIRES Holdings Co., Ltd.

Using ratios such as P/B Ratio 1.10 and PEG Ratio 1.82, investors can assess whether DOUTOR NICHIRES Holdings Co., Ltd. is appropriately valued based on its financials and growth potential. These figures, combined with DOUTOR NICHIRES Holdings Co., Ltd.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for DOUTOR NICHIRES Holdings Co., Ltd.

Financial health indicators, such as Debt/Equity Ratio 0.02 and Cash Flow -, provide a snapshot of DOUTOR NICHIRES Holdings Co., Ltd.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like DOUTOR NICHIRES Holdings Co., Ltd., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for DOUTOR NICHIRES Holdings Co., Ltd.

Investing in DOUTOR NICHIRES Holdings Co., Ltd. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at DOUTOR NICHIRES Holdings Co., Ltd. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;